Apellis Pharmaceuticals Inc (APLS) Insider Trading
- $23,844,337.28
- $105,554,398.32
- March 17, 2025
- Alec Machiels
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 19, 2022 | CEO | 28,200 | $52.06 | Sell | $1,468,092.00 | |
Dec. 15, 2022 | Director | 1,250 | $52.35 | Sell | $65,437.50 | |
Dec. 8, 2022 | Insider | 12,000 | $47.50 | Sell | $570,000.00 | |
Dec. 5, 2022 | Insider | 5,000 | $50.38 | Sell | $251,900.00 | |
Dec. 1, 2022 | Insider | 2,500 | $49.93 | Sell | $124,825.00 | |
Dec. 1, 2022 | Director | 500 | $49.93 | Sell | $24,965.00 | |
Nov. 8, 2022 | Insider | 12,000 | $46.47 | Sell | $557,640.00 | |
Nov. 3, 2022 | Insider | 5,000 | $58.54 | Sell | $292,700.00 | |
Oct. 14, 2022 | Director | 1,250 | $59.31 | Sell | $74,137.50 | |
Oct. 10, 2022 | Insider | 12,000 | $57.50 | Sell | $690,000.00 | |
Oct. 3, 2022 | Insider | 2,500 | $66.69 | Sell | $166,725.00 | |
Sept. 15, 2022 | Director | 1,250 | $66.00 | Sell | $82,500.00 | |
Sept. 8, 2022 | Insider | 12,000 | $63.98 | Sell | $767,760.00 | |
Aug. 17, 2022 | SVP | 5,000 | $69.50 | Sell | $347,500.00 | |
Aug. 15, 2022 | Insider | 12,500 | $69.00 | Sell | $862,500.00 | |
Aug. 15, 2022 | Director | 1,250 | $67.21 | Sell | $84,012.50 | |
Aug. 11, 2022 | Director | 30,000 | $65.63 | Sell | $1,968,900.00 | |
Aug. 11, 2022 | Insider | 12,500 | $67.00 | Sell | $837,500.00 | |
Aug. 11, 2022 | SVP | 5,000 | $67.00 | Sell | $335,000.00 | |
Aug. 3, 2022 | Insider | 5,000 | $56.43 | Sell | $282,150.00 | |
Aug. 1, 2022 | Insider | 2,500 | $55.99 | Sell | $139,975.00 | |
July 27, 2022 | SVP | 5,000 | $57.00 | Sell | $285,000.00 | |
July 19, 2022 | SVP | 5,000 | $56.42 | Sell | $282,100.00 | |
July 15, 2022 | N/A | 1,250 | $46.33 | Sell | $57,912.50 | |
July 15, 2022 | Director | 1,250 | $46.33 | Sell | $57,912.50 | |
July 8, 2022 | Chief Scientific Officer | 12,000 | $47.95 | Sell | $575,400.00 | |
June 27, 2022 | Director | 1,341 | $46.79 | Sell | $62,745.39 | |
June 23, 2022 | Director | 15,000 | $45.00 | Sell | $675,000.00 | |
June 22, 2022 | General Counsel | 10,000 | $44.51 | Sell | $445,100.00 | |
June 17, 2022 | Insider | 2,698 | $45.00 | Sell | $121,410.00 | |
June 16, 2022 | SVP | 10,000 | $41.78 | Sell | $417,800.00 | |
June 15, 2022 | Director | 1,250 | $39.29 | Sell | $49,112.50 | |
June 1, 2022 | Insider | 2,500 | $41.78 | Sell | $104,450.00 | |
May 27, 2022 | Insider | 10,000 | $43.00 | Sell | $430,000.00 | |
May 16, 2022 | Director | 1,250 | $39.18 | Sell | $48,975.00 | |
May 2, 2022 | Insider | 2,500 | $43.56 | Sell | $108,900.00 | |
April 29, 2022 | Insider | 4,000 | $44.43 | Sell | $177,720.00 | |
April 25, 2022 | General Counsel | 5,000 | $50.00 | Sell | $250,000.00 | |
April 20, 2022 | SVP | 7,000 | $52.53 | Sell | $367,710.00 | |
April 14, 2022 | Director | 1,250 | $50.90 | Sell | $63,625.00 | |
April 4, 2022 | Insider | 3,504 | $56.96 | Sell | $199,587.84 | |
April 1, 2022 | Insider | 11,496 | $55.05 | Sell | $632,854.80 | |
March 15, 2022 | Director | 1,250 | $39.57 | Sell | $49,462.50 | |
March 15, 2022 | Insider | 375 | $39.57 | Sell | $14,838.75 | |
Feb. 15, 2022 | Director | 1,250 | $45.43 | Sell | $56,787.50 | |
Feb. 15, 2022 | Insider | 375 | $45.43 | Sell | $17,036.25 | |
Feb. 11, 2022 | Insider | 1,666 | $46.80 | Sell | $77,968.80 | |
Feb. 8, 2022 | Insider | 10,000 | $45.00 | Sell | $450,000.00 | |
Jan. 31, 2022 | Insider | 1,233 | $38.47 | Sell | $47,433.51 | |
Jan. 14, 2022 | Director | 1,250 | $40.56 | Sell | $50,700.00 |
Insiders are both buying and selling Apellis Pharmaceuticals Inc stock.
The insider traders at Apellis Pharmaceuticals Inc are: Alec Machiels, Cedric Francois, Federico Grossi, Pascal Deschatelets, David O Watson, A. Sinclair Dunlop, Mark Jeffrey Delong, Timothy Eugene Sullivan, Adam J Townsend, James George Chopas, Lukas Scheibler, Jeffrey Eisele, Nur Nicholson, Nicole D Perry, Morningside Venture Investment, Karen Lewis, Caroline Baumal, Machiels Alec, Global Strategic Fund I Venbio, Deschatelets Pascal, Victoria L Brown, and Victoria L. Brown
The most active insider trader at Apellis Pharmaceuticals Inc is Alec Machiels with 30 trades.
Cedric Francois has sold the most Apellis Pharmaceuticals Inc stock with a total value of $35,626,981.58.
Morningside Venture Investment has bought the most Apellis Pharmaceuticals Inc stock with a total value of $31,651,764.04.
The most recent insider trade for Apellis Pharmaceuticals Inc was on March 17, 2025.
The single biggest insider buy for Apellis Pharmaceuticals Inc was from Morningside Venture Investment with a total value of $10,000,000.00 on Nov. 18, 2021.
The single biggest insider sell for Apellis Pharmaceuticals Inc was from Cedric Francois with a total value of $16,027,500.00 on March 1, 2024.